The effect of Eurycoma Longifolia on the regulation of reproductive hormones in young males
Open accessAbstract
Eurycoma longifolia supplementation increases testosterone levels in humans via activation of the hypothalamic-pituitary-gonadal axis and/or the hypothalamic-pituitary-adrenal axis mainly in older adults and nonhealthy populations. This study aimed to assess the impact of Eurycoma longifolia on the hypothalamic-pituitary-gonadal and hypothalamic-pituitary-adrenal axes in healthy young males since this might promote functional testosterone prowess. Thirty-two males (24.4 ± 4.7 years; 1.74 ± 0.07 m; 73.7 ± 8.4 kg) in a placebo-controlled, double-blind, matched-paired study received 600 mg/day Eurycoma longifolia or placebo for two weeks. Blood analysis using repeated measures analysis of variance showed significant interaction and time effects for testosterone (F1,30 = 9.04, p = .005), free testosterone (F1,30 = 7.13, p = .012) and estradiol (F1,30 = 8.07, p = .008) levels in favour of the treatment group, while luteinising hormone, follicle-stimulating hormone and sexual hormone-binding globulin did not. The lack of changes in luteinising hormone and follicle-stimulating hormone levels suggests that a lesser role played by Eurycoma longifolia in activating the hypothalamic-pituitary-gonadal axis in the young adults. The raised testosterone level may be due to a greater rate of hormone production via the hypothalamic-pituitary-adrenal axis. The supplementation of Eurycoma longifolia for two weeks demonstrates steroidogenic effects on young men were dose-related. Consequently, the raised testosterone following Eurycoma longifolia supplementations could benefit muscle and strength gain in young adults.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 35 cited sources checked · 0 supported · 0 flagged
- Findingown data
LH, FSH, and SHBG analyses did not reveal any differences between or within group effects.
“Meanwhile, LH, FSH and SHBG analyses did not reveal any differences between and within group effects.”
Quote in the paperNot a substantial claim - Findingown data
Free testosterone was 34% higher at post-intervention in the Eurycoma longifolia group.
“where free testosterone was observed 34% higher at post-intervention in EL.”
Quote in the paperSubstantial claim - Findingcitation
The rise in estradiol observed in this study is still within the normal range of 10 to 82 pg/ml in men.
“However, the rise in estradiol observed in this study is still within the normal range of 10-82 pg/ml in men (Yamamoto et al., 1995).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yamamoto et al., 1995
Not checked in the free run.
- Findingown data
Estradiol was 30% higher at post-intervention in the Eurycoma longifolia group.
“where estradiol was observed 30% higher at post-intervention in EL.”
Quote in the paperSubstantial claim - Findingown data
Testosterone level was 15% higher in the Eurycoma longifolia group after two weeks of consumption.
“Testosterone level was 15% higher in EL following two weeks of consumption.”
Quote in the paperSubstantial claim
- Premisecitation
Several studies found no change in testosterone levels in healthy males aged 19 to 55 years when given Eurycoma longifolia.
“However, several studies have reported a lack of change in testosterone levels in healthy males aged between 19 and 55 years old when given EL (Chen et al., 2014(Chen et al., , 2019;;Ismail et al., 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Chen et al., 2014
Not checked in the free run.
- cites Chen et al., 2019
Not checked in the free run.
- cites Ismail et al., 2012 source
Not checked in the free run.
- Interpretationreasoning
A low Eurycoma longifolia dose of 200 to 400 mg may be insufficient to raise testosterone in a younger population with normal testosterone levels.
“The low dose of EL administered (between 200 and 400 mg) may be insufficient to increase the testosterone levels in a relatively younger population with normal testosterone levels.”
Quote in the paperSubstantial claim - Premisecitation
Dosages between 200 and 400 mg of Eurycoma longifolia increase testosterone levels in men and older men (30 to 72 years) with hypogonadism.
“There is a general consensus that dosages between 200 and 400 mg of EL are able to increase testosterone levels in men and older men (30 to 72 years) with hypogonadism (Henkel et al., 2014;Talbott et al., 2013;Tambi et al., 2012;Udani et al., 2014).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Henkel et al., 2014
Not checked in the free run.
- cites Talbott et al., 2013
Not checked in the free run.
- cites Tambi et al., 2012
Not checked in the free run.
- Premisecitation
In young male adults aged 19 to 35 years, no changes in testosterone levels have been observed when supplemented with a similar dosage of Eurycoma longifolia.
“However, in young male adults (19-35 years), no changes in testosterone levels have been observed when supplemented with a similar dosage of EL (Chen et al., 2014(Chen et al., , 2019)).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Chen et al., 2014
Not checked in the free run.
- cites Chen et al., 2019
Not checked in the free run.
- Interpretationreasoning
This study is the first to suggest that Eurycoma longifolia supplementation increases testosterone via activation of both the HPG and HPA axes.
“Thus, this study is the first to suggest that EL supplementation increases testosterone level via activation of both HPG and HPA axes.”
Quote in the paperNot a substantial claim- Rests on an assumption: Testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.
- Interpretationreasoning
The increases in circulating testosterone and free testosterone may be due to Eurycoma longifolia influencing both the HPA and HPG axes concurrently, not the HPG axis alone.
“In addition, the increases in circulating testosterone and free testosterone may be due to EL influencing both HPA and HPG axis concurrently and not on HPG axis alone.”
Quote in the paperSubstantial claim- Rests on an assumption: Testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.
- Interpretationreasoning
The raised testosterone following Eurycoma longifolia supplementation could benefit muscle and strength gain in young adults.
“Consequently, the raised testosterone following Eurycoma longifolia supplementations could benefit muscle and strength gain in young adults.”
Quote in the paperSubstantial claim - Premisecitation
Eurycomanone inhibits aromatase, the enzyme that converts testosterone to oestrogen.
“and inhibition of aromatase, a key enzyme converting testosterone to oestrogen (Low, Choi, et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Low, Choi, et al., 2013
Not checked in the free run.
- May combine two claims. 22
- Classified as probably not a substantial claim. 7
- The quote only partly states this claim. 1
May combine two claims.
Findingown dataThere was a significant group-by-time interaction for testosterone (F 1,30 = 9.039, p = .005), as well as significant group and time main effects.
“There was a significant interaction between group and time for testosterone (F 1, 30 = 9.039, p = .005),as well as group (F 1, 30 = 4.01, p = .05)and time (F 1, 30 = 4.36, p = .04)main effects.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe present study shows that 600 mg/day of Eurycoma longifolia increases testosterone, free testosterone, and estradiol levels among young adult men.
“In summary, the present study shows that 600 mg/day of EL increases testosterone, free testosterone and estradiol levels among young adult men.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThere was a significant group-by-time interaction for free testosterone (F 1,30 = 7.13, p = .012) and a significant time main effect (F 1,30 = 11.73, p = .002).
“While for free testosterone, there was a significant main interaction between group and time (F 1, 30 = 7.13, p = .012),as well as time main effect (F 1, 30 = 11.73,p = .002)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the current study, two weeks of 600 mg Eurycoma longifolia supplementation alone raised testosterone to 9.24 ng/mL, slightly above the normal human range of 2.64 to 9.16 ng/mL.
“In the current study, 2 weeks of EL supplementation (600 mg) alone (without strength training) raised the testosterone level (9.24 ng/mL) slightly above the normal human range (2.64-9.16ng/mL) as described by Travison et al. (2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Travison et al., 2017
Not checked in the free run.
May combine two claims.
Findingown dataThere was a significant group-by-time interaction for estradiol (F 1,30 = 8.07, p = .008) and a significant time main effect (F 1,30 = 4.22, p = .04).
“As for estradiol, there was a significant interaction between group and time (F 1, 30 = 8.07, p = .008),as well as time main effect (F 1, 30 = 4.22, p = .04)”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationEurycoma longifolia supplementation raises testosterone in humans through activation of the hypothalamic-pituitary-gonadal and/or hypothalamic-pituitary-adrenal axes, mainly in older adults and nonhealthy populations.
“Eurycoma longifolia supplementation increases testosterone levels in humans via activation of the hypothalamic-pituitary-gonadal axis and/or the hypothalamic-pituitaryadrenal axis mainly in older adults and nonhealthy populations.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Chen et al., 2014
Not checked in the free run.
- cites Henkel et al., 2014
Not checked in the free run.
- cites Ismail et al., 2012 source
Not checked in the free run.
- Rests on an assumption: Testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.
May combine two claims.
PremisecitationBioactive compounds in Eurycoma longifolia, including eurycomanone, alleviate sexual dysfunction and hypogonadism in older adults.
“The increase in testosterone levels is attributed to the synergistic effect of bioactive compounds in EL (including eurycomanone), which demonstrate the ability to alleviate sexual dysfunction and hypogonadism among older adults”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Bhat & Karim, 2010
Not checked in the free run.
- cites Ismail et al., 2012 source
Not checked in the free run.
- cites Kotirum et al., 2015
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBioactive compounds in Eurycoma longifolia enhance testosterone steroidogenesis and improve fertility in rats.
“or enhance testosterone steroidogenesis and improve fertility in rats (Low et al., 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Low et al., 2013
Not checked in the free run.
May combine two claims.
PremisecitationEurycoma longifolia alone restores testosterone levels in older adults, those with late-onset hypogonadism, hypertension, diabetes, and moderately stressed individuals.
“Apart from exercise stimulus, consuming EL alone has been shown to be effective in restoring testosterone levels in older adults (Henkel et al., 2014;Talbott et al., 2013;Tambi et al., 2012;Udani et al., 2014) and those with late-onset hypogonadism (LOH) (Tambi et al., 2012), hypertension and diabetes (Henkel et al., 2014) as well as individuals that are moderately stressed (Talbott et al., 2013).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Henkel et al., 2014
Not checked in the free run.
- cites Talbott et al., 2013
Not checked in the free run.
- cites Tambi et al., 2012
Not checked in the free run.
May combine two claims.
Study design and conductown dataAt baseline, there were no significant differences in age, body weight, body fat percentage, and lean body mass between the Eurycoma longifolia and placebo groups.
“At baseline, there were no significant differences in age, body weight, body fat percentage and lean body mass between EL and PLA groups (p > .05).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe higher estradiol and testosterone levels suggest that Eurycoma longifolia may not inhibit the aromatase enzyme, contrary to previous suggestions.
“The higher estradiol and testosterone levels reported suggest that EL may not inhibit the aromatase enzyme.”
- Also stated in: § TA B L E 1 · hedged
“Meanwhile, contrary to previous suggestions the increase in estradiol suggests that the aromatase may not be inhibited.”
Quote in the paperSubstantial claim- Also stated in: § TA B L E 1 · hedged
May combine two claims.
InterpretationcitationThe raised testosterone level may be due to greater hormone production via the HPA axis, possibly through direct adrenal stimulation producing testosterone precursors.
“The raised testosterone level may be due to a greater rate of hormone production via the hypothalamicpituitary-adrenal axis.”
- Also stated in: § TA B L E 1 · hedged
“it is plausible that the increase of testosterone could be due to direct stimulation of the adrenal gland in the HPA axis (Talbott et al., 2006) to produce testosterone precursors”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Talbott et al., 2006
Not checked in the free run.
- Rests on an assumption: Testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.
- Also stated in: § TA B L E 1 · hedged
May combine two claims. The quote only partly states this claim.
Interpretationown dataThe lack of changes in LH and FSH suggests a lesser role of Eurycoma longifolia in activating the HPG axis in young adults, leaving its impact on this axis unclear.
“The lack of changes in luteinising hormone and follicle-stimulating hormone levels suggests that a lesser role played by Eurycoma longifolia in activating the hypothalamic-pituitary-gonadal axis in the young adults.”
- Also stated in: § 4 | D ISCUSS I ON · hedged
“The lack of changes in LH, FSH and SHBG levels suggests a lesser effect of EL on HPG axis after two weeks of supplementation.”
Quote in the paperSubstantial claim- Rests on an assumption: Testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.
- Also stated in: § 4 | D ISCUSS I ON · hedged
Classified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenStatistical assumptions of normality, homogeneity of variances, compound symmetry, and homogeneity of regression were checked and fulfilled.
“Assumptions of normality, homogeneity of variances, compound symmetry, and homogeneity of regression were checked and fulfilled.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataThe study used a placebo-controlled, double-blind, body weight matched-pairs design.
“The study is a placebo-controlled, double-blind, body weight matched-pairs design where participants were allocated into two groups: E. longifolia group (EL) (n = 16) and placebo group (PLA) (n = 16).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAdherence to the protocol was assessed using a dietary recall diary and text message reminders.
“Participants' adherence to the protocol was assessed using the dietary recall diary where time they took the supplement and how they felt at different times during the day were recorded.Additionally, reminders were sent out via text messages to ensure compliance.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataTwo weeks of 600 mg/day Eurycoma longifolia supplementation demonstrates dose-related steroidogenic effects on young men, increasing testosterone compared with previous lower-dose studies.
“The supplementation of Eurycoma longifolia for two weeks demonstrates steroidogenic effects on young men were dose-related.”
- Also stated in: § 4 | D ISCUSS I ON · boosted
“The dosage of 600 mg EL (8.7 mg of eurycomanone) used in the current study increased testosterone level in young males (18-30 years) and demonstrates the steroidogenic effects of the herb on young males were dose-related when compared with previous studies”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Chen et al., 2014
Not checked in the free run.
- cites Chen et al., 2019
Not checked in the free run.
- cites Henkel et al., 2014
Not checked in the free run.
- Also stated in: § 4 | D ISCUSS I ON · boosted
May combine two claims.
InterpretationcitationEurycoma longifolia is known to contain active flavonoids and quassinoids, which could potentially increase testosterone via the HPG and HPA axes by converting testosterone precursors.
“EL is known to have active flavonoids (Bashir et al., 2017;Khanam et al., 2014) and quassinoids (Darise et al., 1982;Miyake et al., 2009;Tung et al., 2017), which could potentially increase testosterone levels via the HPG and as well via the HPA axis by converting the testosterone precursors.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Bashir et al., 2017
Not checked in the free run.
- cites Khanam et al., 2014
Not checked in the free run.
- cites Darise et al., 1982
Not checked in the free run.
- Rests on an assumption: Testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.
May combine two claims.
PremisecitationStimulation of the HPA axis increases cortisol production, which reduces HPG activity.
“Meanwhile, stimulation of the HPA axis in general increases cortisol production, which reduces HPG activity (Chen et al., 1997;Sherman et al., 2016;Viau, 2002).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Chen et al., 1997
Not checked in the free run.
- cites Sherman et al., 2016
Not checked in the free run.
- cites Viau, 2002
Not checked in the free run.
- Rests on an assumption: Testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.
May combine two claims.
Study design and conductown dataThe Eurycoma longifolia extract used was a single batch of Physta water extract with eurycomanone content of 1.45% w/v, complying with the Malaysian Standard.
“The EL used in the present study complied with the standard since eurycomanone content was 1.45 w/v (%).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Malaysian Standard (2011)
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningA plausible alternative explanation for the increase in testosterone is direct stimulation of the adrenal gland in the HPA axis converting testosterone precursors to testosterone, not entirely from HPG axis activation.
“A plausible alternative explanation on the increase in testosterone could be due to the direct stimulation of the adrenal gland in the HPA axis converting testosterone precursor to testosterone and not entirely from the activation of the HPG axis.”
Quote in the paperSubstantial claim- Rests on an assumption: Testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.
Classified as probably not a substantial claim.
PremisecitationIn animals, eurycomanone-induced testosterone increases are attributed to elevated LH and FSH stimulating Leydig cells to produce testosterone.
“It has been proposed that, in animals, the increased testosterone levels when given eurycomanone could be attributed to elevated gonadotropins, luteinising hormone (LH) and follicle-stimulating hormone (FSH) that stimulate the Leydig cells to produce testosterone (Low et al., 2013)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Low et al., 2013
Not checked in the free run.
May combine two claims.
Study design and conductown dataAll participants complied with supplementation (100% compliance) and no adverse effects were reported.
“All participants complied with the supplementation (100% compliance), and no adverse effects were reported.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningAdministration of an increased Eurycoma longifolia dosage of 600 mg/day for two weeks can increase testosterone in young male participants and could potentially have a positive impact on sports performance.
“Hence, administration of an increased dosage of EL (600 mg/day) for two weeks can increase the testosterone level among young male participants and therefore could potentially have a positive impact on sports performance.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationEurycoma longifolia extract lowers cortisol and raises testosterone through conversion of testosterone precursors in the HPA axis.
“However, it is suggested that EL extract lowers cortisol and increases testosterone levels through the conversion of testosterone precursors in the HPA axis (Talbott et al., 2006(Talbott et al., , 2013)).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Talbott et al., 2006
Not checked in the free run.
- cites Talbott et al., 2013
Not checked in the free run.
- Rests on an assumption: Testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.
The paper relies on this without support.
Testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.
“Physiologically, testosterone levels in the body are regulated predominantly via the HPG axis and to a lesser extent the HPA axis.”
The paper relies on this without support.
Research examining the effect of Eurycoma longifolia extract on HPG and HPA axis activation in a young adult population is scarce.
“However, research examining the effect of EL extract (standardised to eurycomanone content) on the activation of the HPG and HPA axis in a young adult population is scarce.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The increase in testosterone after E. longifolia has been found to be associated with an effect on the HPA.
“The increase in testosterone has been found to be associated with an effect on the HPA.[Citation85]”
From Ergogenic properties, safety evaluation and regulations of selected ingredients in testosterone booster dietary supplements (2024) · cites this paper as [85]
The study’s summary reports increased testosterone after E. longifolia supplementation in young men. It describes an HPA-axis pathway as a plausible explanation, not an established association: the discussion says the proposed mechanisms need further investigation, and the study did not establish an effect on the HPA axis. (LLM, conf=0.85)
Experimental — accuracy not yet measuredApplication of 600 mg of E. longifolia extract (standard eurycomanone 1.45%) each day for 2 weeks increased testosterone, free testosterone, and estradiol levels among young men aged 24.4 ± 4.7 years.
“The application of 600 mg of E. longifolia extract (standard is eurycomanone 1.45%) each day for 2 weeks contributed to increased testosterone, free testosterone, and estradiol levels among young men (age 24.4 ± 4.7 years).”
From Ergogenic properties, safety evaluation and regulations of selected ingredients in testosterone booster dietary supplements (2024) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Placebo estradiol confidence interval excludes its mean change
MajorThe placebo estradiol means imply a pre-minus-post change of −10.77 pg/mL, but the reported confidence interval for the difference runs from −7.56 to 12.23 pg/mL. An interval for that difference cannot exclude its own point estimate.
“PLA 53.33 ± 16.14 64.10 ± 23.40”
“-7.56 to 12.23 .54”
Placebo FSH interval is centered on a different change
MinorThe placebo FSH means imply a pre-minus-post change of −0.14 mIU/mL, while the reported confidence interval is centered at 0.78 mIU/mL. These do not describe the same estimated difference.
“PLA 5.00 ± 1.44 5.14 ± 1.97”
“-0.28 to 1.84 .73”
Cites
Functional Cross‐Talk Between the Hypothalamic‐Pituitary‐Gonadal and ‐Adrenal Axes
Viau, V. (2002) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2002.00798.x · Cited by 744 · see citing works
Viau, V., & Meaney, M. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-05-01866.1996 · Cited by 347 · see citing works
Travison, T. G., Vesper, H. W., Orwoll, E., Wu, F., Kaufman, J. M., Wang, Y., Lapauw, B., Fiers, T., Matsumoto, A. M., & Bhasin, S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2935 · Cited by 326 · see citing works
Tongkat Ali (Eurycoma longifolia Jack): A review on its ethnobotany and pharmacological importance
Bhat, R., & Karim, A. A. (2010) · Fitoterapia · doi:10.1016/j.fitote.2010.04.006 · Cited by 236 · see citing works
Seale, J. V., Wood, S. A., Atkinson, H. C., Harbuz, M. S., & Lightman, S. L. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01258.x · Cited by 235 · see citing works
Rege, J., Nakamura, Y., Satoh, F., Morimoto, R., Kennedy, M. R., Layman, L. C., Honma, S., Sasano, H., & Rainey, W. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2912 · Cited by 227 · see citing works
Androgen and Glucocorticoid Receptor Heterodimer Formation
Chen, S.-Y., Wang, J., Yu, G.-Q., Liu, W., & Pearce, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14087 · Cited by 200 · see citing works
Functions of estrogen and estrogen receptor signaling on skeletal muscle
Ikeda, K., Horie‐Inoue, K., & Inoue, S. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105375 · Cited by 200 · see citing works
McLachlan, R. I., O’Donnell, L., Meachem, S. J., Stanton, P. G., de Kretser, D. M., PRATIS, K., & Robertson, D. M. (2002) · Journal of Andrology · doi:10.1002/j.1939-4640.2002.tb02607.x · Cited by 179 · see citing works
Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?
Binder, S. (2011) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-301236 · Cited by 170 · see citing works
Assessment of steroidogenesis and steroidogenic enzyme functions
Luu-The, V. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.05.017 · Cited by 161 · see citing works
Aromatase inhibitors in men: effects and therapeutic options
de Ronde, W., & de Jong, F. H. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-93 · Cited by 155 · see citing works
Estrogen status and skeletal muscle recovery from disuse atrophy
McClung, J. M., Davis, J. M., Wilson, M. A., Goldsmith, E. C., & Carson, J. A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01583.2005 · Cited by 147 · see citing works
Mucuna pruriens improves male fertility by its action on the hypothalamus–pituitary–gonadal axis
Shukla, K. K., Mahdi, A. A., Ahmad, M. K., Shankhwar, S. N., Rajender, S., & Jaiswar, S. P. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.045 · Cited by 146 · see citing works
The interaction of testosterone and cortisol is associated with attained status in male executives.
Sherman, G. D., Lerner, J. S., Josephs, R. A., Renshon, J., & Gross, J. J. (2015) · Journal of Personality and Social Psychology · doi:10.1037/pspp0000063 · Cited by 143 · see citing works
Ovariectomy prevents the recovery of atrophied gastrocnemius skeletal muscle mass
Sitnick, M., Foley, A. M., Brown, M., & Spangenburg, E. E. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00869.2005 · Cited by 128 · see citing works
Mylonas, I. G., Brüning, A., Shabani, N., Kunze, S., & Kupka, M. S. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-1 · Cited by 125 · see citing works
Pöllänen, E., Sipilä, S., Alén, M., Ronkainen, P. H. A., Ankarberg‐Lindgren, C., Puolakka, J. O., Suominen, H., Hämäläinen, E. K., Turpeinen, U., Konttinen, Y. T., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00701.x · Cited by 121 · see citing works
Tambi, M. I. B. M., Imran, M. K., & Henkel, R. R. (2012) · Andrologia · doi:10.1111/j.1439-0272.2011.01168.x · Cited by 120 · see citing works
Low, B., Das, P. K., & Chan, K. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.11.013 · Cited by 113 · see citing works
Self-citationAguilera, R., Chapman, T. E., Starcevic, B., Hatton, C. K., & Catlin, D. H. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.2.292 · Cited by 107 · see citing works
Rogerson, S., Riches, C. J., Jennings, C., Weatherby, R. P., Meir, R. A., & Marshall-Gradisnik, S. M. (2007) · The Journal of Strength and Conditioning Research · doi:10.1519/r-18395.1 · Cited by 105 · see citing works
Low, B., Choi, S. B., Wahab, H. A., Das, P. K., & Chan, K. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.06.023 · Cited by 97 · see citing works
Self-citationTalbott, S., Talbott, J. A., George, A. A., & Pugh, M. (2013) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-10-28 · Cited by 82 · see citing works
Hirsutism and the Variable Response of the Pilosebaceous Unit to Androgen
Rosenfield, R. L. (2005) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1111/j.1087-0024.2005.10106.x · Cited by 68 · see citing works
Dismukes, A. R., Johnson, M. M., Vitacco, M. J., Iturri, F., & Shirtcliff, E. A. (2014) · Developmental Psychobiology · doi:10.1002/dev.21231 · Cited by 63 · see citing works
Ismail, S. B., Wan Mohammad, W. M. Z., George, A., Nik Hussain, N. H., Musthapa Kamal, Z. M., & Liske, E. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/429268 · Cited by 61 · see citing works
Eurycomanone and eurycomanol, quassinoids from the roots of Eurycoma longifolia
Darise, M., Kohda, H., Mizutani, K., & Tanaka, O. (1982) · Phytochemistry · doi:10.1016/0031-9422(82)83050-1 · Cited by 60 · see citing works
Henkel, R., Wang, R., Bassett, S. H., Chen, T., Liu, N., Zhu, Y., & Tambi, M. I. B. M. (2013) · Phytotherapy Research · doi:10.1002/ptr.5017 · Cited by 55 · see citing works
Quassinoids from Eurycoma longifolia
Miyake, K., Tezuka, Y., Awale, S., Li, F., & Kadota, S. (2009) · Journal of Natural Products · doi:10.1021/np900486f · Cited by 55 · see citing works
Expression of steroidogenic enzymes and sex-steroid receptors in human prostate
Pelletier, G. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.02.004 · Cited by 53 · see citing works
Estrogen administration attenuates immobilization-induced skeletal muscle atrophy in male rats.
Sugiura, T., Ito, N., Goto, K., Naito, H., Yoshioka, T., & Powers, S. (2006) · Journal of Physiological Sciences · doi:10.2170/physiolsci.rp006906 · Cited by 45 · see citing works
Ishikawa, T., Glidewell-Kenney, C., & Jameson, J. L. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.09.004 · Cited by 45 · see citing works
Udani, J. K., George, A. A., Musthapa, M., Pakdaman, M. N., & Azreena, A. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/179529 · Cited by 41 · see citing works
Kotirum, S., Ismail, S. B., & Chaiyakunapruk, N. (2015) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2015.07.009 · Cited by 41 · see citing works
SERUM ESTRADIOL LEVELS IN NORMAL MEN AND MEN WITH IDIOPATHIC INFERTILITY
Yamamoto, M., Hibi, H., Katsuno, S., & Miyake, K. (1995) · International Journal of Urology · doi:10.1111/j.1442-2042.1995.tb00619.x · Cited by 32 · see citing works
Abubakar, B. M., Salleh, F. M., & Wagiran, A. (2017) · Journal of Applied Sciences · doi:10.3923/jas.2017.324.338 · Cited by 28 · see citing works
Shoyama, Y., Tung, N., Uto, T., Hai, N., & Li, G. (2017) · Pharmacognosy Magazine · doi:10.4103/pm.pm_353_16 · Cited by 28 · see citing works
Dehydroepiandrosterone and dehydroepiandrosterone sulfate metabolism in human genital skin
KAUFMAN, F. R., Stanczyk, F. Z., Matteri, R. K., Gentzschein, E., Delgado, C., & Løbo, R. A. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53698-x · Cited by 26 · see citing works
Gonadotrophin-releasing hormone analogue-induced manipulation of testicular function in the monkey
Weinbauer, G. F., & Eberhard, N. (1993) · Human Reproduction · doi:10.1093/humrep/8.suppl_2.45 · Cited by 25 · see citing works
Detection and Quantification of Eurycomanone Levels in Tongkat Ali Herbal Products
Mohamed, A. N., Vejayan, J., & Yusoff, M. M. (2015) · Journal of Applied Sciences · doi:10.3923/jas.2015.999.1005 · Cited by 21 · see citing works
Sekiyama, F. M., Rodrigues, R., Mesas, A. E., González, A. D., & de Andrade, S. M. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_40_18 · Cited by 20 · see citing works
Chen, C. K., Mohammad, W. M. Z. W., Ooi, F. K., Ismail, S. B., Abdullah, M. R., & George, A. A. (2014) · PubMed Central · Cited by 17 · see citing works
Increasing Circulating Testosterone: Impact of Herbal Dietary Supplements
Gunnels, T. A., & Bloomer, R. J. (2014) · Journal of Plant Biochemistry & Physiology · doi:10.4172/2329-9029.1000130 · Cited by 17 · see citing works
Jayusman, P. A., Mohamed, I. N., Alias, E., Dom, S. M., & Shuid, A. N. (2018) · Journal of X-Ray Science and Technology · doi:10.3233/xst-17366 · Cited by 13 · see citing works
Monoclonal antibody c262 counteracts the stimulatory effect of progesterone on sperm–oocyte fusion
Pandolfi, C., Macerola, B., Zugaro, A., Santucci, R., Francavilla, S., & Francavilla, F. (2005) · International Journal of Andrology · doi:10.1111/j.1365-2605.2004.00504.x · Cited by 11 · see citing works
Chen, C. K., Ooi, F. K., Kasim, N. A. A., & Asari, M. A. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_404_17 · Cited by 11 · see citing works
Hameid, A. S. B., Al-Sindi, T. A., Allow, A. K., Nafie, E. M., Al-Ahmad, B. E. M., & Faisal, G. G. (2019) · Oman Medical Journal · doi:10.5001/omj.2019.45 · Cited by 9 · see citing works
Azarnioushan, F., Khatamsaz, S., & Elah, S. H. (2009) · Armaghane Danesh · Cited by 8 · see citing works
Rahman, S. A., Ahmad, N. A., Samat, N. H. A., Zahri, S., Abdullah, A. R., & Chan, K. (2016) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2016.07.016 · Cited by 7 · see citing works
Self-citationGeorge, A. A. (2013) · Journal of Sports Medicine & Doping Studies · doi:10.4172/2161-0673.1000127 · Cited by 6 · see citing works
Flagged first, then by citations
1 of the 52 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Khanam Z., 2014, Phytochemical analyses and DNA cleavage activity of Citrus maxima fruit
- Malaysian Standard, 2011, Phytopharmaceutical aspects of freeze dried water extract from Tongkat Ali roots‐specification, 12
- Prakash G., 2007, Reproductive biology, 12.8
- Talbott S., 2006, Effect of eurycoma longifolia extract on anabolic balance during endurance exercise [abstract], Journal of International Society Sports Nutrition, 3, S32
- Tambi M. I. M., 2005, Standardised water‐soluble extract of Eurycoma longifolia (LJ100) on men's health, International Journal of Andrology, 28, 27
Cited by
Sorted by citations
Botanicals in health and disease of the testis and male fertility: A scoping review
Shepherd, A., Brunckhorst, O., Ahmed, K., & Xu, Q. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154398 · Cited by 30 · see citing works
Leisegang, K., Finelli, R., Sikka, S. C., & Selvam, M. K. P. (2022) · Medicina · doi:10.3390/medicina58081047 · Cited by 18 · see citing works
Testosterone Boosters Intake in Athletes: Current Evidence and Further Directions
Lazarev, A., & Bezuglov, E. (2021) · Endocrines · doi:10.3390/endocrines2020011 · Cited by 14 · see citing works
Do “testosterone boosters” really increase serum total testosterone? A systematic review
Morgado, A., Tsampoukas, G., Sokolakis, I., Schoentgen, N., Ürkmez, A., & Sarıkaya, S. (2023) · International Journal of Impotence Research · doi:10.1038/s41443-023-00763-9 · Cited by 12 · see citing works
Jędrejko, M., Jędrejko, K., Granda, D., Kała, K., Pokrywka, A., & Muszyńska, B. (2026) · Nutrients · doi:10.3390/nu18050781 · Cited by 7 · see citing works
Jędrejko, K., Lazarev, A., Jędrejko, M., & Muszyńska, B. (2024) · Food Reviews International · doi:10.1080/87559129.2023.2238055 · Cited by 4 · see citing works
Bratchikov, O. I., Tyuzikov, I. A., & Grekov, E. A. (2023) · Research Results in Pharmacology · doi:10.18413/rrpharmacology.9.10060 · Cited by 3 · see citing works
The Effect of Tongkat Ali Supplementation on Body Composition in Exercise-Trained Males and Females
António, J., Evans, C., Pereira, F., Thakkar, H., Miriyala, V., Rocanelli, R., Castillo, C., Andal, A., Rojas, J., Santana, J. C., et al. (2024) · Applied Sciences · doi:10.3390/app14114372 · Cited by 2 · see citing works
Natural Remedies for the Treatment of Andrological Problems
Nelli, G., Salleh, N., & Kumar, G. G. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-6737-4.ch018
Gujja, S. R. A. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24415102646
Francos, K. Y., Kouakou, V. D. N., & Djadji, L. T. A. (2024) · International Journal of Biological and Chemical Sciences · doi:10.4314/ijbcs.v18i2.4
elspeiy, M., Zeitoun, M. M., El-Sawy, M., Abaza, I. M., Sadaka, T. A., Shahba, H. A., Abdelaal, M. A., Abdella, M. M., & Sweed, A. Y. (2025) · Journal of Veterinary Medical Research · doi:10.21608/jvmr.2025.413070.1137
Pan, J., Bao, R., Chen, Q., Wu, Y., Chen, B., Zhu, Z., Xie, J., Zhang, Y., Wang, T., & Wang, D. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117787
- Authors
- Chan, K. Q., Stewart, C., Chester, N., Hamzah, S. H., & Yusof, A.
- Affiliations
- University of Malaya (MY)
- Liverpool John Moores University (GB)
- Corresponding author
- Yusof, Ashril
- Venue
- Andrologia
- Publisher
- Wiley
- Published
- 2021-02-09
- Volume
- 53
- Issue
- 4
- Pages
- e14001-e14001
- ISSN
- 0303-4569 (ISSN-L)
- 1439-0272
- OpenAlex
- W3127473645
- Semantic Scholar
- ff0dbaf6f8da26786d24ea7cb4feb4c72b3a2c9a
- Cited by
- 12
- References
- 52
- Citations by year
- 2026: 2 · 2024: 3 · 2023: 4 · 2022: 2 · 2021: 1
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Andrologia (publishedVersion)
- PubMed (publishedVersion)
- Liverpool John Moores University (acceptedVersion)
- Funders
- Universiti Malaya
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- Eurycoma longifolia, testosterone, reproductive hormones, hypothalamic-pituitary-gonadal axis, hypothalamic-pituitary-adrenal axis, estradiol, free testosterone, luteinizing hormone, follicle-stimulating hormone, young men, herbal supplementation
- MeSH terms
- Aged, Double-Blind Method, Humans, Hypothalamo-Hypophyseal System, Male, Pituitary-Adrenal System, Plant Extracts, Testosterone, Eurycoma, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review